The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Merkel polyoma virus specific T-cell receptor transgenic T-cell therapy in PD-1 inhibitor refractory Merkel cell carcinoma.
 
Joshua Veatch
Stock and Other Ownership Interests - Lyell Immunopharma
Research Funding - Lyell Immunopharma
Patents, Royalties, Other Intellectual Property - Lyell Immunopharma
 
Kelly Paulson
No Relationships to Disclose
 
Yuta Asano
No Relationships to Disclose
 
Lauren Martin
No Relationships to Disclose
 
Bo Lee
No Relationships to Disclose
 
Evan Thomas Hall
Research Funding - ImCheck therapeutics (Inst); Nektar (Inst); Neoleukin Therapeutics (Inst); Treatment Technologies and Insights (Inst)
Travel, Accommodations, Expenses - Novartis
Other Relationship - Cancer Support Community
 
Shailender Bhatia
Stock and Other Ownership Interests - Moderna Therapeutics
Honoraria - Bristol-Myers Squibb; EMD Serono; EMD Serono; Genentech/Roche; Sanofi/Regeneron; Sanofi/Regeneron
Consulting or Advisory Role - Bristol Myers Squibb; Bristol-Myers Squibb; EMD Serono; EMD Serono; Exicure; Genentech/Roche; Sanofi/Regeneron; Sanofi/Regeneron; Sanofi/Regeneron (Inst)
Research Funding - 4SC (Inst); Bristol-Myers Squibb (Inst); Checkmate Pharmaceuticals (Inst); EMD Serono (Inst); Exicure (Inst); Immune Design (Inst); Incyte (Inst); Merck (Inst); NantWorks (Inst); Nektar (Inst); Novartis (Inst); OncoSec (Inst); Seven and Eight Biopharmaceuticals (Inst)
Travel, Accommodations, Expenses - NantWorks; Sanofi/Regeneron
 
Paul Nghiem
Leadership - Society for Investigative Dermatology (SID)
Honoraria - UpToDate; UpToDate
Consulting or Advisory Role - 4SC; EMD Serono; Merck Sharp & Dohme; Pfizer; Pfizer/EMD Serono; Sanofi/Regeneron
Research Funding - Bristol-Myers Squibb; EMD Serono
Patents, Royalties, Other Intellectual Property - Patent filed: "Merkel cell polyomavirus T antigen-specific TCRs and uses thereof" (Inst); Patent pending for high affinity T cell receptors that target the Merkel polyomavirus.
Travel, Accommodations, Expenses - Merck Sharp & Dohme; Sanofi/Regeneron
 
Aude Chapuis
Stock and Other Ownership Interests - Affini-T Therapeutics; SignalOne Bio; TScan Therapeutics
Research Funding - Affini-T Therapeutics; Amazon; Lonza; SignalOne Bio
Patents, Royalties, Other Intellectual Property - Affini-T Therapeutics; SignalOne Bio; TScan Therapeutics